Sidra Medicine, a Qatar Foundation entity, will host the Precision Medicine and the Future of Genomics 2024 Summit (PMFG 2024) from December 3-5 at the Qatar National Convention Centre.
PMFG 2024 will focus on three main pillars: Genomics for All, Precision Diagnostics, and Advanced Therapeutics. It will bring together leading experts, innovators, and stakeholders from around the world to explore the latest advancements in these key areas of personalised healthcare.
Dr Iyabo Tinubu-Karch, CEO of Sidra Medicine said: "Qatar is at the forefront of precision medicine, thanks to local entities like Sidra Medicine, Hamad Medical Corporation, Qatar Foundation, Qatar Precision Health Institute and other partners. Our combined efforts highlight pioneering therapies and world-class research that have ultimately positioned Sidra Medicine as an experienced healthcare organisation on programmes related to genetic and genomic medicine, pediatric rare diseases and precision health."
Dr Ammira Akil, principal investigator and the lead of the Genetic and Metabolic Disorders Clinical Research Programme at Sidra Medicine and organising chair of PMFG 2024 said: "The future of precision medicine in Qatar will be showcased at PMFG 2024, a testament to the power of collaboration. We are bringing together the brightest minds in healthcare, research, technology, and policy to share knowledge, forge partnerships, and drive the next wave of innovation. PMFG 2024 will highlight advancements in precision medicine, including newborn genome sequencing, population genomics, precise diagnostics and breakthrough therapies.”
With a focus on ethical considerations and real-world implementation, PMFG 2024 attendees will discover how early genomic information can personalise newborn care, explore large-scale genomic advancements and their integration into healthcare systems, and uncover targeted treatment breakthroughs for complex and rare diseases.
Prof Khalid Fakhro, chief research officer at Sidra Medicine noted: "Over the past decade, we have witnessed incredible strides in precision medicine, and Sidra Medicine continues to play a critical role in shaping the future of precision health in the Middle East. Thanks to our role in establishing a comprehensive well-characterised database of Arab genomic data and disease cohorts – we are increasingly becoming a source of knowledge, inspiration and collaboration for healthcare institutes from around the world.”
Renowned physician-scientist, Dr Robert Green, who is a professor of medicine (Genetics) from Harvard Medical School, will be the opening keynote speaker at PMFG 2024. Dr Green is widely recognised for his leadership in the MedSeq and BabySeq Projects, which have provided crucial early data on the clinical utility and cost-effectiveness of comprehensive genomic sequencing in newborns.
Dr Ammira Akil and Prof Khalid Fakhro
